KEROS THERAPEUTICS INC shareholders Q3 2023

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

KEROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Allspring Global Investments Holdings, LLC 124$3,9530.00%
Invesco Ltd. 16,551$527,6450.00%
Lindbrook Capital, LLC 19$6060.00%
NATIONAL BANK OF CANADA /FI/ 30$9250.00%
BANK OF AMERICA CORP /DE/ 54,650$1,742,2420.00%
OSAIC HOLDINGS, INC. 884$28,1790.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 3,114$99,2740.00%
PRINCIPAL FINANCIAL GROUP INC 6,512$207,6030.00%
ALLIANCEBERNSTEIN L.P. 21,120$673,3060.00%
UBS Group AG 6,587$209,9940.00%
ROYAL BANK OF CANADA 5,123$164,0000.00%
JPMORGAN CHASE & CO 53,069$1,691,8400.00%
PUTNAM INVESTMENTS LLC 9,721$309,9060.00%
Citadel Advisors 600$19,1280.00%
Citadel Advisors 100$3,1880.00%
SCHRODER INVESTMENT MANAGEMENT GROUP 7,917$253,6610.00%
JANE STREET GROUP, LLC 10,606$338,1190.00%
Covestor Ltd 3$00.00%
Daiwa Securities Group Inc. 111$40.00%
JANUS HENDERSON GROUP PLC 9,832$313,0560.00%
External links

This page lists KEROS THERAPEUTICS INC's shareholders in Q3 2023. To view KEROS THERAPEUTICS INC's shareholder history, click here.